These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15999996)

  • 1. Identification of novel extracellular signal-regulated kinase docking domain inhibitors.
    Hancock CN; Macias A; Lee EK; Yu SY; Mackerell AD; Shapiro P
    J Med Chem; 2005 Jul; 48(14):4586-95. PubMed ID: 15999996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure.
    Chen F; Hancock CN; Macias AT; Joh J; Still K; Zhong S; MacKerell AD; Shapiro P
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6281-7. PubMed ID: 17000106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9.
    Boston SR; Deshmukh R; Strome S; Priyakumar UD; MacKerell AD; Shapiro P
    BMC Cancer; 2011 Jan; 11():7. PubMed ID: 21219631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma.
    Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Bräse S; Ibrahim MAA; Nieger M; Garvalov BK; Dalby KN; Kaoud TS
    Bioorg Chem; 2019 Feb; 82():290-305. PubMed ID: 30396063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying specific kinase substrates through engineered kinases and ATP analogs.
    Kumar NV; Eblen ST; Weber MJ
    Methods; 2004 Apr; 32(4):389-97. PubMed ID: 15003601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.
    Sammons RM; Perry NA; Li Y; Cho EJ; Piserchio A; Zamora-Olivares DP; Ghose R; Kaoud TS; Debevec G; Bartholomeusz C; Gurevich VV; Iverson TM; Giulianotti M; Houghten RA; Dalby KN
    ACS Chem Biol; 2019 Jun; 14(6):1183-1194. PubMed ID: 31058487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.
    Samadani R; Zhang J; Brophy A; Oashi T; Priyakumar UD; Raman EP; St John FJ; Jung KY; Fletcher S; Pozharski E; MacKerell AD; Shapiro P
    Biochem J; 2015 May; 467(3):425-38. PubMed ID: 25695333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
    Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
    Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering.
    Aksan Kurnaz I
    Biotechnol Bioeng; 2004 Dec; 88(7):890-900. PubMed ID: 15515167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
    Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
    Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.
    Sananbenesi F; Fischer A; Schrick C; Spiess J; Radulovic J
    Mol Cell Neurosci; 2002 Nov; 21(3):463-76. PubMed ID: 12498787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
    Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
    Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.